Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Year-over-year book value per share growth
Latest
-37.41%
↓ 119% vs avg
Percentile
P28
Within normal range
Streak
3 qtr
Consecutive declineDecelerating
Average
-17.11%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -37.41% |
| Q2 2025 | -29.20% |
| Q1 2025 | -12.00% |
| Q4 2024 | 5.80% |
| Q3 2024 | -10.49% |
| Q2 2024 | 18.49% |
| Q1 2024 | -76.12% |
| Q4 2023 | -158.78% |
| Q3 2023 | -164.67% |
| Q2 2023 | -14.77% |
| Q1 2023 | -37.79% |
| Q4 2022 | -20.85% |
| Q3 2022 | -15.89% |
| Q2 2022 | -29.15% |
| Q1 2022 | 101.43% |
| Q4 2021 | 10.09% |
| Q3 2021 | -17.19% |
| Q2 2021 | -30.48% |
| Q1 2021 | 44.72% |
| Q4 2020 | -14.17% |
| Q3 2020 | -17.15% |
| Q2 2020 | -49.57% |
| Q1 2020 | 109.73% |
| Q4 2019 | -19.75% |
| Q3 2019 | -36.88% |
| Q2 2019 | 182.81% |
| Q1 2019 | -82.94% |
| Q4 2018 | 15.67% |
| Q3 2018 | -23.81% |
| Q2 2018 | -40.34% |
| Q1 2018 | -29.86% |
| Q4 2017 | 10.09% |
| Q3 2017 | -40.34% |
| Q2 2017 | -53.50% |
| Q1 2017 | -44.82% |
| Q4 2016 | -56.18% |
| Q3 2016 | -33.31% |
| Q2 2016 | 62.54% |
| Q1 2016 | -35.64% |
| Q4 2015 | -12.80% |